Senate Panel Moves Forward on Stabilization Bill
With the September 27 deadline for insurers to sign contracts to sell insurance on HealthCare.gov fast approaching, the Senate’s health panel has to move quickly to stabilize the insurance markets. According to The Hill, the panel expects to have a bipartisan bill sometime early next week that can pass the Senate by the end of the month. The stabilization bill is expected to fund the cost-sharing reduction payments to insurers, allow more people to buy catastrophic plans, and give states more flexibility.
Vote to Repeal DC’s Death With Dignity Law
The House of Representatives has passed a bill that would block the District of Columbia’s assisted suicide law. The bill also blocks DC from subsidizing abortion for low-income individuals, The Washington Post reported. The Senate still has to weigh in, and if it chooses not to act, then it would stall these measures from taking effect. The assisted suicide law passed the DC Council by a vote of 11 to 2 after more than a year of discussion. It would allow terminally ill patients to choose how and when they died.
New Medicare Cards in the Mail
All 60 million beneficiaries enrolled in Medicare will receive new cards created to combat identify theft and fraud. The agency is beginning its outreach campaign and the rollout for the new cards will begin in April, according to NPR. The new cards will include new ID numbers that are a randomly generated sequence of 11 numbers and letters—until now, Medicare used people’s Social Security numbers.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More